Anti-Tissue Transglutaminase IgA Antibodies
NCT04019223 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 22
Last updated 2019-07-15
Summary
Celiac disease is the most common genetically related food intolerance, worldwide. It is an immune mediated intolerance to gluten (from wheat, barley, or rye) in genetically susceptible individuals .The disease primarily affects the small intestine, where it progressively leads to flattening of the small intestinal mucosa .
Conditions
- Celiac Disease in Children
Interventions
- DIAGNOSTIC_TEST
-
anti-tissue transglutaminase group
Determination of anti-tissue transglutaminase IgA antibodies serum level.
- DIAGNOSTIC_TEST
-
biopsy group
Intestinal biopsy for histopathology study the jejunal histopathological
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-10-01
- Primary Completion
- 2020-09-30
- Completion
- 2021-03-01
More Related Trials
-
Celiac Disease Diagnosis in Patients With Weakly Positive Serum Anti-Transglutaminase: Duodenal Anti-Endomysium Assay.
NCT02242123 ·Status: COMPLETED
-
A Blood Based Diagnostic Test for Coeliac Disease
NCT02442219 ·Status: COMPLETED
-
Coeliac Disease in the Nord-Trøndelag Health Study (HUNT)
NCT04041622 ·Status: COMPLETED ·Phase: NA
-
Celiac Disease Prevention
NCT00617838 ·Status: UNKNOWN ·Phase: NA
-
No-biopsy Approach in Celiac Disease: Cut-off Points for IgA Anti-tissue Transglutaminase Assays
NCT05983978 ·Status: RECRUITING
-
Use of a Home Test for Gluten Detection in Urine and Its Effect on Gluten-free Diet Adherence
NCT05119322 ·Status: SUSPENDED ·Phase: NA
-
Can a Very High Result From a Screening Test for Celiac Disease be Used to Diagnose Celiac Disease?
NCT00175760 ·Status: COMPLETED
-
HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease
NCT01100099 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Rapid Technique for the Detection of Intestinal Anti-transglutaminase Antibodies
NCT05786183 ·Status: UNKNOWN
-
Interpretation of Serological Tests in the Diagnosis of Celiac Disease: Anti-deamidated Gliadin Peptide Antibodies Revisited
NCT03320811 ·Status: COMPLETED
-
Oral AGY for Celiac Disease
NCT01765647 ·Status: COMPLETED ·Phase: PHASE1
-
PTG-100 for Patients With Celiac Disease
NCT04524221 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge
NCT03409796 ·Status: COMPLETED ·Phase: NA
-
Gluten Reduction and Risk of Celiac Disease
NCT04593888 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Immune Responses to Gluten
NCT05209568 ·Status: RECRUITING ·Phase: NA
-
T Cell Receptor (TCR) Sequencing and Transcriptional Profiling in Adult Celiac Disease Patients Undergoing Gluten Challenge
NCT04614571 ·Status: COMPLETED ·Phase: NA
-
Iron Deficiency and TTG Normalization
NCT05675280 ·Status: COMPLETED
-
Mass Screening for the Early Detection of Patients With Celiac Disease.
NCT05186038 ·Status: COMPLETED
-
Vedolizumab Induction May Prevent Celiac Enteritis
NCT02929316 ·Status: TERMINATED ·Phase: PHASE2
-
Pre-endoscopy Serological Testing for Coeliac Disease; a Novel Approach Using Rapid Antibody Testing
NCT02834429 ·Status: COMPLETED
-
Immune Response in Celiac Disease on In-vitro Gluten Challenge
NCT01909050 ·Status: COMPLETED
-
"Adding DNA-test for Screening of HLA-DQ2 and DQ8 to Improve Early Diagnosis of Celiac Disease"
NCT06179121 ·Status: ENROLLING_BY_INVITATION
-
Effects of Home Gluten Immunogenic Peptide Testing on Children With Celiac Disease
NCT03462979 ·Status: SUSPENDED ·Phase: NA
-
Celiac Disease Screening
NCT01902368 ·Status: TERMINATED ·Phase: NA
-
Autoimmune Diseases And Serum Anti-Nuclear Antibodies Positivity In Non-Celiac Wheat Sensitivity Patients
NCT02248545 ·Status: COMPLETED